DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Hepatitis B Virus (HBV) Therapeutics - Current and Future Players" report to their offering.
The report is a vital source of up-to-date information with in-depth analysis on the companies in the rapidly growing HBV Market. The report identifies and analyses the key companies shaping and driving the global HBV market. The report provides insight into the competitive HBV landscape, including new companies entering the market. This report is built using data and information sourced from proprietary databases, primary and secondary and in-house analysis by our team of industry experts.
Scope
- Investigation of current and future market competition for HBV
- Competitor assessment
- Coverage of key market players and company profiles including business description, financial overview and SWOT analysis.
- Strategic assessment of HBV sector through market impact analysis, future market scenario and company analysis
Reasons to buy
- Gain a high level view of the trends shaping and driving HBV market
- Assess competitiveness of products in market by understanding the strengths and weaknesses of current competition.
- Create an effective counter-strategy to gain a competitive advantage against those currently in the market
- What's the next big thing in the global HBV market landscape? Identify,
- Understand and capitalize
Key Topics Covered:
1 Tables & Figures
2 Introduction
3 Market Outlook
3.1 Global Markets
3.1.1 Forecast
3.1.2 Drivers and Barriers - Global Issues
4 Current and Future Players
4.1 Overview
4.2 Trends in Corporate Strategy
4.3 Company Profiles
4.3.1 Gilead
4.3.2 Bristol-Myers Squibb
4.3.3 Roche
4.3.4 Merck
4.3.5 GSK
4.3.6 Novartis
4.3.7 Arrowhead Research
4.3.8 GlobeImmune
5 Appendix
For more information visit http://www.researchandmarkets.com/research/brq3jk/hepatitis_b_virus
